91无码一区人妻A片蜜,免费视频三区,免费成人网站视频,成年人视频大全,日韩视频在线播放,国产999999久久99999,精品一区二区免费视频,欧美午夜影院

<button id="eiezk"><video id="eiezk"></video></button>

產品名稱

C5, Mouse Antibody from HYCULT BIOTECH

產品貨號

HM1073-IA

產品價格

現(xiàn)貨詢價，電話：010-67529703

產品規(guī)格

0.5 mg

產品品牌

HYCULT BIOTECH

產品概述

產品詳情

Edit	&nbsp
Antigenic Specificity	C5, Mouse
Clone	BB5.1
Host Species	Mouse
Reactive Species	mouse, rat
Isotype	IgG1
Format	unconjugated
Size	0.5 mg
Concentration	100 μg/ml
Applications	frozen sections, functional studies, immunoassay, IF, IP, paraffin sections
Reviews / Ratings	If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description	The monoclonal antibody BB5.1 binds the fifth component of mouse complement (C5). The complement system is a group of plasma and cell membrane proteins that play a key role in the immune system. All three pathways (classical, alternative and lectin) lead to the cleavage of C3 and eventually the formation of the cytolytic membrane attack complex C5b-9. If the activation cascade is allowed to proceed beyond the cleaving of C3 into C3a and C3b, an additional C3b molecule binds to the C3 convertases. This generates the C5 convertase (C3bBbC3b for the alternative pathway and C4bC2bC3b for the classical and lectin pathways). C5 convertase cleaves C5, releases the potent anaphylactic peptide C5a and generates C5b. C5b can initiate the terminal pathway , which recruits the components C6, C7, C8 and C9 to the surface of the target and inserts the C9 complex as a pore (termed the terminal complement complex) into the membrane. C5a is the most potent anaphylatoxin and a powerful chemotaxin for neutrophils and monocytes, with the ability to promote margination, extravasation, and activation of these cells. Thus, blocking C5 may be required for optimal inhibition of the inflammatory response. At the same time, inhibition of the complement cascade at C5 does not impair the generation of C3b through the classical and alternative pathways, preserving C3b-mediated opsonization of pathogenic microorganisms as well as opsonization and solubilization of immune complexes. C5 is synthesised in the liver as a single polypeptide chain and is present in serum in a concentration of 50-80 ?μm/ml. Before secretion the molecule is glycosylated and secreted into plasma as a 190 kDa glycoprotein consisting of a disulphide linked alpha-chain (111 kDa) and beta-chain (75 kDa). Monoclonal antibody BB5.1 has been shown to precipitate the two chains of C5 from normal mouse serum and inhibited C5-dependent hemolysis in a functional complement test. Furthermore, BB5.1 administration completely inhibits terminal complement activity in murine models for antibody-mediated rejection (AMR) during heart and kidney transplantation. In another mouse model, both pre-treatment as well as intervention with monoclonal antibody BB5.1 attenuates disease development during anti-MPO IgG-induced glomerulonephritis. Blockage of C5 activation by BB5.1 protects against renal ischemia-reperfusion injury by inhibition of late apoptosis and inflammation. In Lupus disease, combination therapy of anti-IL-10/anti-C5 (BB5.1) can both prevent and reduce the effect of the humoral immune response.
Immunogen	Purified C5
Other Names	Complement C5, Hemolytic complement.
Gene, Accession #	C5
Catalog #	HM1073-IA
Price
Order / More Info	C5, Mouse Antibody from HYCULT BIOTECH
Product Specific References	n/a
產品資料

<button id="eiezk"><video id="eiezk"></video></button>